Recombinant Rat BCAN Protein (Baculovirus)，His & Myc

BCAN, or Brevican, is a member of the link protein family, primarily found in the central nervous system and playing a critical role in the structure and functionality of the extracellular matrix in the brain. Research into BCAN recombinant proteins has gained attention due to their potential implications in understanding various neurological disorders, including traumatic brain injury, multiple sclerosis, and certain neurodegenerative diseases. The ability to produce BCAN in a recombinant form allows for in-depth studies of its biochemical properties and interactions with other matrix components, potentially leading to insights into neural repair mechanisms and synaptic functions. By elucidating the roles of BCAN in the extracellular matrix, researchers aim to develop targeted therapeutic strategies that can enhance recovery following neural injuries or mitigate the progression of neurodegenerative conditions. Current studies are focused on characterizing the structural and functional aspects of BCAN, evaluating its interactions with other proteins, and investigating its effects on neuronal health and plasticity. Furthermore, as the field of regenerative medicine evolves, BCAN recombinant proteins may serve as crucial tools for developing novel biomaterials to support neural tissue engineering and promote repair in damaged neural environments. Overall, the study of BCAN recombinant proteins represents a vital area of research with the potential to advance our understanding of brain homeostasis and pathology, driving forward therapeutic innovations for neurological health.